Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Kit Helps Assess Total Patient Antioxidant Status

By LabMedica International staff writers
Posted on 24 Sep 2009
A total antioxidant status (TAS) kit complements a wide range of antioxidant products enabling a complete profile of a patient's antioxidant status.

Antioxidant levels can aid identification of disease risk in conditions such as cardiovascular disease, diabetes, cancer, and rheumatoid arthritis. More...
Information from antioxidant status can be used to optimize treatment regimes. The TAS kit can also be employed for food and beverage analysis and to assess the antioxidant potential of drugs.

Antioxidants help defend the body against free radicals, which are highly reactive molecules that have been implicated in the development of over 100 diseases affecting all major organs in the body. Many diseases have been associated with low antioxidant levels.

The Randox (Crumlin, UK) TAS kit is a cost-effective, easy to use method that provides rapid analysis and can be automated on most clinical chemistry analyzers. Calibrators and controls are available to enhance testing facilities. Antioxidant products available from Randox include albumin, bilirubin, ferritin, glutathione reductase, glutathione peroxide, superoxide dismutase, total iron binding content, transferrin, and uric acid.

Randox develops, manufactures, and markets clinical diagnostic products worldwide. It's core products are biochip array technology; clinical chemistry analyzers and reagents; quality controls; and recombinant proteins and antibodies.

Related Links:

Randox




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.